Patent Assignment
Reel/Frame 057698/0356
Change of Name
Recorded: 2021-10-03
Pages: 12
Assignor
NESTLÉ SKIN HEALTH S.A.
Executed: 2020-01-29
Assignee
GALDERMA HOLDING SA
RUE D'ENTRE-DEUX-VILLES, 10, LA TOUR-DE-PEILZ, 1814, SWITZERLAND
Covered Properties
(48)
Homogeneously Formulating microdosed active principles
Application:
11/269,854 →
Publication:
US 2006/0115501
Dermatological cream-gels containing avermectin compounds
Homogeneously Formulating Microdosed Active Principles
Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea
Application:
11/898,911 →
Publication:
US 2008/0139488
Solubilizing of Metronidazole
Production of Bepromoline
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Application:
12/059,086 →
Publication:
US 2009/0093421
Inverse Emulsions Comprising Avermectins and Cosmetic/Dermatological Applications Thereof
Compositions Comprising at Least One Aqueous Phase and at Least One Fatty Phase Which Comprises Avermectin Compounds
Double compartment skincare products comprising avermectin/milbemycin compounds
Dermatological Compositions Comprising Avermectin Nanocapsules
Administration of Fluocinolone Acetonide, Tretinoin and Hydroquinone Cream in Melasma Maintenance Therapy
Preparation of Amorolfine
Solubilizing of metronidazole
Application:
12/610,996 →
Publication:
US 2010/0048645
Compositions Comprising Avermectin/Azelaic Acid Compounds Useful for Treating, E.G., Rosacea
Application:
12/830,576 →
Publication:
US 2011/0165100
Production of Bepromoline
Method for Solubilizing Metronidazole
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Compositions Comprising Avermectin/Azelaic Acid Compounds Useful for Treating E.G., Rosacea
Dermatological Compositions Comprising Avermectin Nanocapsules
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Compositions Comprising at Least One Aqueous Phase and at Least One Fatty Phase Which Comprises Avermectin Compounds
Compositions Comprising Avermectin/Azelaic Acid Compounds Useful for Treating, E.G., Rosacea
Topical Wash Composition for Use in Acne Patients
Application:
14/122,955 →
Publication:
US 2014/0121176
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Bpo Wash Gel Composition
Bpo Wash Emulsion Composition
Use of a Macrocyclic Lactone for Treating a Complication from a Papilloma Virus Infection
Process for Preparing a Cross-Linked Hyaluronic Acid Product
Prostaglandin F2Alpha and Analogues Thereof for Treating Atrophic Cutaneous Scarring
Single-Step Functionalization and Cross-Linking of Hyaluronic Acid
Compound of the Avermectin Family or of the Milbemycin Family for the Treatment and/or Prevention of Atopic Dermatitis
Application:
15/100,302 →
Publication:
US 2017/0000812
Lubrication of an Injection Needle
Method of Reducing Hair Loss Associated with Chemotherapy
Cross-Linked Hyaluronic Acid Grafted with Dextran
Method of Treating Hand-Foot Syndrome and Symptoms Associated Therewith
Application:
15/319,429 →
Publication:
US 2017/0136013
Enantiopure or Enantioenriched Bdde and Its Use as Crosslinking Agent in the Manufacture of Cross-Linked Products
Compositions Comprising a Compound from the Family of Avermectins and an Agonist Compound for at Least One of the Retinoic Acid Receptors for Treating Acne
Compound from the Avermectin Family for Treating and/or Preventing Folliculitis
Compound of the Avermectin Family or of the Milbemycin Family for the Treatment and/or Prevention of Atopic Dermatitis
A Process for Preparing a Composition Comprising a High Concentration of One or More Avermectins
Method of Reducing Hair Loss Associated with Chemotherapy
Topical Wash Composition for Use in Acne Patients
Carbohydrate Crosslinker
Syringe
A Syringe
Process for Preparing a Cross-Linked Hyaluronic Acid Product
Application:
16/111,493 →
Publication:
US 2019/0062461
Method of Treating Hand-Foot Syndrome and Symptoms Associated Therewith
Application:
16/867,412 →
Publication:
US 2020/0390762
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2012
From: KAOUKHOV, ALEXANDRE; VILLARD, CHRISTOPHE; BOUISSOU, PHILIPPE
To: GALDERMA S.A.
Reel/Frame 029465/0642 →
Assignment of Assignor's Interest
Dec 13, 2012
From: KAOUKHOV, ALEXANDRE; VILLARD, CHRISTOPHE; BOUISSOU, PHILIPPE
To: GALDERMA S.A.
Reel/Frame 029465/0673 →
Assignment of Assignor's Interest
Jun 3, 2014
From: MALLARD, CLAIRE; BRZOKEWICZ, ALAIN
To: GALDERMA S.A.
Reel/Frame 033021/0430 →
Assignment of Assignor's Interest
Jun 3, 2014
From: MALLARD, CLAIRE; BRZOKEWICZ, ALAIN
To: GALDERMA S.A.
Reel/Frame 033021/0364 →
Assignment of Assignor's Interest
Jun 3, 2014
From: MALLARD, CLAIRE; BRZOKEWICZ, ALAIN
To: GALDERMA S.A.
Reel/Frame 033019/0235 →
Asset Transfer Agreement
Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
Change of Address
Jun 28, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 060541/0374 →